|John Husnik, c.e.o. of Renaissance BioScience|
“The acceptance of our acrylamide-reducing yeast as GRAS by the U.S. F.D.A. is a significant step forward in the commercialization and marketing of the AR yeast for a wide variety of food and beverage sectors,” said John Husnik, chief executive officer of Vancouver-based Renaissance BioScience.
The National Toxicology Program characterizes acrylamide as “reasonably anticipated to be a human carcinogen.” The F.D.A. in March issued final guidance to the food industry on ways to reduce acrylamide levels. A chemical, acrylamide may form during high-temperature cooking such as frying, roasting and baking.